Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Arthritis News
Tuesday, November 03, 2009 Naproxen/Nexium Combo Prevents Ulcers in OA Patients
Combining naproxen esomeprazole magnesium relieves OA pain while protecting the stomach...
Thursday, October 22, 2009 For Early RA, Start with Six Months of MTX, then Add Two More DMARDs
ACR researchers report that initial treatment with methotrexate followed by step-up to two more DMARDs if needed at 6 months is as good as adding a TNF inhibitor...
Thursday, October 22, 2009 Water, Skim Milk May Stave Off Gout Attacks
Encouraging gouty arthritis patients to drink more water and/or skim milk may lead to fewer gout attacks...
Wednesday, October 21, 2009 Phase 2 Data Support Pfizer's JAK Inhibitor for RA
Two Phase 2 trials reported at ACR show efficacy of JAK inhibitor now in Phase 3...
Tuesday, October 20, 2009 Infliximab Plus MTX for JIA
Infliximab plus methotrexate (MTX) bests combinations of traditional disease modifying drugs and/or MTX alone for the treatment of polyarticular juvenile idiopathic arthritis...
Monday, October 19, 2009 Experts Call for Early Intervention with Hip Scopes
As presented at the annual meeting of the International Society for Hip Arthroscopy, earlier intervention is better when it comes to joint-sparing hip operations...
Thursday, October 15, 2009 To Scope or Not to Scope in Hip Patients Over 60
Hip arthroscopy may benefit some patients aged 60 and older with femoroacetebular impingement...
Tuesday, October 13, 2009 Protalix Reports First Data on Generic Enbrel™
Plant cell fusion protein would be first “biosimilar” version of etanercept...
Tuesday, October 06, 2009 Simponi Scores EU OK for RA, PsA, AS
Simponi (golimumab) anti-TNF is the first monthly anti-TNF injectable to gain broad EU approval...
Friday, October 02, 2009 NicOx Files Naproxcinod NDA, the first CINOD for OA
NicOx has filed an NDA for naproxcinod, the first in the new class of cyclooxygenase-inhibiting nitric oxid donators (CINODs) for OA treatment...